CLINICAL ROLE -
Medical professionals share insights on treatment considerations and patient selection for bispecific antibody therapy and the process for referring patients to other institutions for care.
Quadruple Therapies Including Immunotherapy Agents Show Benefit in Multiple Myeloma
Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma
Sixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting
FDA Accepts Isatuximab for Priority Review for Treatment of Transplant-Ineligible Multiple Myeloma
Study Uncovers Demographic Disparities in Access to AutoHCT Therapy for Patients with Multiple Myeloma
A Novel Bispecific Anti-GPRC5D × CD3 Antibody: A New Treatment Paradigm in Multiple Myeloma